Risk-Stratified Breast Cancer Screening Incorporating a Polygenic Risk Score: A Survey of UK General Practitioners’ Knowledge and Attitudes

by Aya Ayoub, Julie Lapointe, Hermann Nabi, Nora Pashayan
Published 2023-03-01

Women’s perception, attitudes, and intended behavior towards predictive epigenetic risk testing for female cancers in 5 European countries: a cross-sectional online survey

by Odette Wegwarth, Nora Pashayan, Martin Widschwendter, Felix G. Rebitschek
Published 2019-05-01

Do cancer risk and benefit-harm ratios influence women's consideration of risk-reducing mastectomy? A scenario-based experiment in five European countries.

by Felix G Rebitschek, Nora Pashayan, Martin Widschwendter, Odette Wegwarth
Published 2019-01-01

Of Screening, Stratification, and Scores

by Bartha M. Knoppers, Alexander Bernier, Palmira Granados Moreno, Nora Pashayan
Published 2021-07-01

A Systematic Review and Critical Assessment of Breast Cancer Risk Prediction Tools Incorporating a Polygenic Risk Score for the General Population

by Cynthia Mbuya-Bienge, Nora Pashayan, Cornelia D. Kazemali, Julie Lapointe, Jacques Simard, Hermann Nabi
Published 2023-11-01

Cost-Effectiveness of Early Detection and Prevention Strategies for Endometrial Cancer—A Systematic Review

by Gaby Sroczynski, Artemisa Gogollari, Annette Conrads-Frank, Lára R. Hallsson, Nora Pashayan, Martin Widschwendter, Uwe Siebert
Published 2020-07-01

Do Health Professionals Need Additional Competencies for Stratified Cancer Prevention Based on Genetic Risk Profiling?

by Susmita Chowdhury, Lidewij Henneman, Tom Dent, Alison Hall, Alice Burton, Paul Pharoah, Nora Pashayan, Hilary Burton
Published 2015-06-01

Trends in lung cancer emergency presentation in England, 2006–2013: is there a pattern by general practice?

by Camille Maringe, Nora Pashayan, Francisco Javier Rubio, George Ploubidis, Stephen W. Duffy, Bernard Rachet, Rosalind Raine
Published 2018-05-01

Assessing eligibility for lung cancer screening using parsimonious ensemble machine learning models: A development and validation study.

by Thomas Callender, Fergus Imrie, Bogdan Cebere, Nora Pashayan, Neal Navani, Mihaela van der Schaar, Sam M Janes
Published 2023-10-01

Assessing eligibility for lung cancer screening using parsimonious ensemble machine learning models: A development and validation study

by Thomas Callender, Fergus Imrie, Bogdan Cebere, Nora Pashayan, Neal Navani, Mihaela van der Schaar, Sam M. Janes
Published 2023-10-01

Represent: A community engagement roadmap to improve participant representation in cancer early detection research: An Oregon case study

by Jessica Currier, Ignacia Arteaga, Hannah Turner-Uaandja, Bella Starling, Nora Pashayan, Christina Jäderholm, Christopher Ponce Campuzano, Jackilen Shannon
Published 2023-03-01

Polygenic risk-tailored screening for prostate cancer: A benefit-harm and cost-effectiveness modelling study.

by Tom Callender, Mark Emberton, Steve Morris, Ros Eeles, Ros Eeles, Zsofia Kote-Jarai, Paul D P Pharoah, Nora Pashayan
Published 2019-12-01

Using Real-World Data to Determine Health System Costs of Ontario Women Screened for Breast Cancer

by Nicole Mittmann, Soo Jin Seung, Christina Diong, Jodi M. Gatley, Michael Wolfson, Marie-Hélène Guertin, Nora Pashayan, Jacques Simard, Anna M. Chiarelli
Published 2022-10-01

Phenotypes and rates of cancer-relevant symptoms and tests in the year before cancer diagnosis in UK Biobank and CPRD Gold.

by Matthew Barclay, Cristina Renzi, Antonis Antoniou, Spiros Denaxas, Hannah Harrison, Samantha Ip, Nora Pashayan, Ana Torralbo, Juliet Usher-Smith, Angela Wood, Georgios Lyratzopoulos
Published 2023-12-01

Phenotypes and rates of cancer-relevant symptoms and tests in the year before cancer diagnosis in UK Biobank and CPRD Gold

by Matthew Barclay, Cristina Renzi, Antonis Antoniou, Spiros Denaxas, Hannah Harrison, Samantha Ip, Nora Pashayan, Ana Torralbo, Juliet Usher-Smith, Angela Wood, Georgios Lyratzopoulos
Published 2023-12-01

Interruption of cancer screening services due to COVID-19 pandemic: lessons from previous disasters

by Douglas M. Puricelli Perin, Tess Christensen, Andrea Burón, Jennifer S. Haas, Aruna Kamineni, Nora Pashayan, Linda Rabeneck, Robert Smith, Miriam Elfström, Mireille J.M. Broeders
Published 2021-09-01

DNA methylation at quantitative trait loci (mQTLs) varies with cell type and nonheritable factors and may improve breast cancer risk assessment

by Chiara Herzog, Allison Jones, Iona Evans, Michal Zikan, David Cibula, Nadia Harbeck, Nicoletta Colombo, Angelique Flöter Rådestad, Kristina Gemzell-Danielsson, Nora Pashayan, Martin Widschwendter
Published 2023-09-01

Should Age-Dependent Absolute Risk Thresholds Be Used for Risk Stratification in Risk-Stratified Breast Cancer Screening?

by Nora Pashayan, Antonis C. Antoniou, Andrew Lee, Michael Wolfson, Jocelyne Chiquette, Laurence Eloy, Andrea Eisen, Tracy L. Stockley, Hermann Nabi, Jennifer D. Brooks, Michel Dorval, Douglas F. Easton, Bartha Maria Knoppers, Anna M. Chiarelli, Jacques Simard
Published 2021-09-01

Alcohol Intake and Alcohol–SNP Interactions Associated with Prostate Cancer Aggressiveness

by Hui-Yi Lin, Xinnan Wang, Tung-Sung Tseng, Yu-Hsiang Kao, Zhide Fang, Patricia E. Molina, Chia-Ho Cheng, Anders E. Berglund, Rosalind A. Eeles, Kenneth R. Muir, Nora Pashayan, Christopher A. Haiman, Hermann Brenner, Jong Y. Park, The PRACTICAL Consortium
Published 2021-02-01

Gynecologic Cancer Risk and Genetics: Informing an Ideal Model of Gynecologic Cancer Prevention

by Lauren C. Tindale, Almira Zhantuyakova, Stephanie Lam, Michelle Woo, Janice S. Kwon, Gillian E. Hanley, Bartha Knoppers, Kasmintan A. Schrader, Stuart J. Peacock, Aline Talhouk, Trevor Dummer, Kelly Metcalfe, Nora Pashayan, William D. Foulkes, Ranjit Manchanda, David Huntsman, Gavin Stuart, Jacques Simard, Lesa Dawson
Published 2022-06-01